These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22753293)

  • 21. TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.
    Uramoto H; Onitsuka T; Shimokawa H; Hanagiri T
    Anticancer Res; 2010 Oct; 30(10):4309-15. PubMed ID: 21036757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of lung cancer patients enrolled in CTEP (cancer therapy evaluation program)-sponsored phase I trials.
    Gadgeel SM; Ivy P; Chen W; Mauer J; Smith D; Lorusso P
    Clin Lung Cancer; 2011 Jul; 12(4):218-23. PubMed ID: 21726820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the elderly patient with advanced non-small cell lung cancer.
    Cheong KA; Chrystal K; Harper PG
    Int J Clin Pract; 2006 Mar; 60(3):340-3. PubMed ID: 16494650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
    Kishimoto T
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):304-9. PubMed ID: 12795187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular predictors of response to chemotherapy in non-small cell lung cancer.
    Andrews J; Yeh P; Pao W; Horn L
    Cancer J; 2011; 17(2):104-13. PubMed ID: 21427554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.
    Du G; Yang Y; Zhang Y; Sun T; Liu W; Wang Y; Li J; Zhang H
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):893-904. PubMed ID: 23355038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
    Gridelli C; Massarelli E; Maione P; Rossi A; Herbst RS; Onn A; Ciardiello F
    Cancer; 2004 Oct; 101(8):1733-44. PubMed ID: 15386339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for advanced stage non-small cell lung cancer.
    Fathi AT; Brahmer JR
    Semin Thorac Cardiovasc Surg; 2008; 20(3):210-6. PubMed ID: 19038730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of PS2 patients with advanced non-small cell lung cancer.
    Cheong KA; Chrystal K; Harper PG
    Int J Clin Pract; 2006 Nov; 60(11):1493-6. PubMed ID: 16911572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy in the management of patients with inoperable non-small cell lung cancer.
    Carney DN
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):71-5. PubMed ID: 9007127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
    Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
    Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gefitinib combined with stereotactic radiosurgery in previously treated patients with advanced non-small cell lung cancer.
    Wang Z; Zhu XX; Wu XH; Li B; Shen TZ; Kong QT; Li J; Liu ZB; Jiang WR; Wang Y; Hou B
    Am J Clin Oncol; 2014 Apr; 37(2):148-53. PubMed ID: 23211223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of patients with advanced non-small-cell lung cancer.
    Rivera MP
    Curr Opin Pulm Med; 2001 Jul; 7(4):247-58. PubMed ID: 11470982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-small cell lung cancer in the elderly: defining treatment options.
    Vora N; Reckamp KL
    Semin Oncol; 2008 Dec; 35(6):590-6. PubMed ID: 19027463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial peptides as novel therapeutics for non-small cell lung cancer.
    Kunda NK
    Drug Discov Today; 2020 Jan; 25(1):238-247. PubMed ID: 31786365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial for the Special Issue "Advances in the Development of Anticancer Drugs".
    Fotie J
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer during pregnancy: A narrative review.
    Mitrou S; Petrakis D; Fotopoulos G; Zarkavelis G; Pavlidis N
    J Adv Res; 2016 Jul; 7(4):571-4. PubMed ID: 27408759
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.